GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct - Wikidata - wikimedia - TriplyDB

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

http://www.wikidata.org/entity/Q35061297

about

Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.Intraductal papillary neoplasm of the bile ducts: A case report and literature review Intraductal papillary neoplasms of the bile duct Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern.Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas.GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.The curious case of Gαs gain-of-function in neoplasia.

P2860

Q31162502-80D1BD4F-B90F-460A-8AD8-98F3BE3B9B78 Q34121347-C8687999-0C4A-4089-96DD-7A09D2C3FDD9 Q35537214-82CCFC11-2800-4A14-B506-9551080BAA3F Q35926362-D65131F7-19C8-4CC5-BD01-78976CBF9AC4 Q36290444-560E0FB8-BADF-4A6C-BA8F-4974136F6255 Q38221859-DCBDE01D-91A5-4243-A5DC-423AF8AD49AD Q38920606-B52AD51A-19AA-48FB-BBEB-D5737DF3B639 Q40654013-CDFD7DDC-BD7E-409F-9D3B-04499297F8F0 Q48367735-5D3B3651-F326-4A1D-AF54-A114723D56BB Q50545897-485AFFE4-353D-460B-952E-79C64384C51F Q51687417-C48CBF7D-7802-46B0-B8AB-769A361ED72E Q54169714-B4AC65D1-AB16-4137-9F09-DB888453D5E3 Q54955004-A92495FB-CE40-40C3-B145-3F4AC8ACB3C7

P2860

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

http://www.wikidata.org/entity/Q35061297

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@ast

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@en

type

label

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@ast

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@en

prefLabel

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@ast

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@en

P1433

Q35061297-3FE20692-0625-419B-B0CB-C27BDC2060AD

P1476

Q35061297-2D1330BD-9370-42F6-8294-B3674CAD3E37

P2093

Q35061297-1B713AC9-8FE5-4E83-BF3C-D8DDBF487866

Q35061297-35502BC0-C699-4025-B5DA-3C05383ED71A

Q35061297-53E422FD-661B-4094-8453-83E7237E0A86

Q35061297-8FFD3D9B-0A08-44AB-8B14-5DDDDACF4BBF

Q35061297-D8CEBDCC-27CB-4238-9CF8-7BFB3BD7311F

P2860

Q35061297-17ECFD5B-53DB-4169-9569-AC9D4C545F73

Q35061297-2253254D-A017-4AFD-9E24-8A2D51BD3CF4

Q35061297-271ECD59-BB5E-449A-A2CF-427A96C1B7D3

Q35061297-3059A884-E207-4C06-B36C-42B70D2FA3ED

Q35061297-45F39D5D-8648-4B1A-A6CC-060659750C03

Q35061297-4973C498-B3A6-4836-B82D-2F777D9298BF

Q35061297-4EF5A62B-F43D-4DEE-B4E9-CED8220D7A2C

Q35061297-4F4E0C54-FEE0-4FD1-97D3-48476FE2A314

Q35061297-5550D5FB-9339-46A0-AC31-419BA3F3DB6D

Q35061297-6EE07C47-95A7-421B-AAD6-B6F7A8A5D8B6

P304

Q35061297-55CFF30C-4D12-4315-ACF4-3C6DCA963421

P31

Q35061297-0FC2D1EC-D1E1-47FF-9E4C-46F09D26E015

P356

Q35061297-E9D78047-11ED-41A1-9193-54A491DCAF4C

P407

Q35061297-53379CF8-7EF5-421E-9B52-84315DFECA4C

P433

Q35061297-4AE7C0F3-58E4-4B7E-A772-193BE8A052CA

P478

Q35061297-7B020460-B00F-4E5F-88CE-888106BADBE7

P577

Q35061297-11FD4BB5-1E8C-4C79-818C-539C11F1619C

P5875

Q35061297-B4BCFC2F-BF4E-4B95-9A25-72E9956953FC

P698

Q35061297-E4457F0D-2D77-456D-A3AA-9D98871083E0

P932

Q35061297-F436C87A-B75D-4D03-A39A-F99D36B15B25

P356

JOURNAL.PONE.0081706

P1433

P1476

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

@en

P2093

Motoko Sasaki

http://www.w3.org/2001/XMLSchema#string

Takashi Matsubara

http://www.w3.org/2001/XMLSchema#string

Takeo Nitta

http://www.w3.org/2001/XMLSchema#string

Yasuni Nakanuma

http://www.w3.org/2001/XMLSchema#string

Yasunori Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.

GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.

Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms

Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.

A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas?

Lamellar structures of MUC2-rich mucin: a potential role in governing the barrier and lubricating functions of intestinal mucus.

Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.

P304

e81706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0081706

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259209314

http://www.w3.org/2001/XMLSchema#string

P698

24312577

http://www.w3.org/2001/XMLSchema#string

P932

3847161

http://www.w3.org/2001/XMLSchema#string